Burden of Illness Economic Model for Patients with Non-alcoholic Steatohepatitis (NASH) in the United States

被引：0
|
作者：
Younossi, Zobair M. [1 ,2 ]
Priyadarshini, Masoom [2 ]
Afendy, Mariam [2 ]
Nader, Fatema [3 ]
Younossi, Issah [3 ]
Racila, Andrei [2 ,3 ]
Stepanova, Maria [3 ]
机构：
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[3] Ctr Outcomes Res Liver Dis, Washington, DC USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2114
引用
收藏
页码：1115A / 1116A
页数：2
相关论文
共 50 条
  • [1] ECONOMIC BURDEN OF PROGRESSION TO CIRRHOSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES
    Patil, D.
    Qiu, Y.
    Kou, T. D.
    Myers, J.
    Burns, L.
    VALUE IN HEALTH, 2019, 22 : S179 - S179
  • [2] Economic Burden of Progression to Cirrhosis in Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
    Patil, Dhaval
    Qiu, Ying
    Kou, Tzuyung
    Myers, Joel
    Nandal, Aditya
    Burns, Leah
    HEPATOLOGY, 2018, 68 : 435A - 435A
  • [3] Economic and clinical burden of non-alcoholic steatohepatitis in patients with type II diabetes in the United States
    Younossi, Zobair
    Tampi, Radhika
    Racilla, Andrei
    Qiu, Ying
    Burns, Leah
    Younossi, Issah
    Nader, Fatema
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E312 - E313
  • [4] Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
    Younossi, Zobair M.
    Tampi, Radhika
    Priyadarshini, Massoom
    Nader, Fatema
    Younossi, Issah M.
    Racila, Andrei
    HEPATOLOGY, 2019, 69 (02) : 564 - 572
  • [5] THE VALUE OF CURING ADVANCED NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES
    Younossi, Zobair M.
    Tampi, Radhika
    Nader, Fatema
    Younossi, Issah M.
    Cable, Rebecca
    Srishord, Manirath K.
    Racila, Andrei
    GASTROENTEROLOGY, 2019, 156 (06) : S1234 - S1234
  • [6] Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
    Alice Morgan
    Sally Hartmanis
    Emmanuel Tsochatzis
    Philip N. Newsome
    Stephen D. Ryder
    Rachel Elliott
    Lefteris Floros
    Richard Hall
    Victoria Higgins
    George Stanley
    Sandrine Cure
    Sharad Vasudevan
    Lynne Pezzullo
    The European Journal of Health Economics, 2021, 22 : 505 - 518
  • [7] Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018
    Morgan, Alice
    Hartmanis, Sally
    Tsochatzis, Emmanuel
    Newsome, Philip N.
    Ryder, Stephen D.
    Elliott, Rachel
    Floros, Lefteris
    Hall, Richard
    Higgins, Victoria
    Stanley, George
    Cure, Sandrine
    Vasudevan, Sharad
    Pezzullo, Lynne
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2021, 22 (04): : 505 - 518
  • [8] Non-alcoholic steatohepatitis (NASH)
    Michael F. Sorrell
    Sandeep Mukherjee
    Current Treatment Options in Gastroenterology, 1999, 2 (6) : 447 - 450
  • [9] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [10] The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
    Witkowski, Michal
    Moreno, Soren Ilsoe
    Fernandes, Joao
    Johansen, Pierre
    Augusto, Margarida
    Nair, Sunita
    PHARMACOECONOMICS, 2022, 40 (08) : 751 - 776
12345